Video-assisted thoracoscopic lobectomy: an unavoidable trend? A retrospective single-institution series of 410 cases
Open Access
- 16 April 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (1) , 36-43
Abstract
Evaluation of the feasibility, safety and oncological validity of video-assisted thoracic lobectomy (VATS). The VATS study exclusion criteria included T3 or T4 tumours, central hilar tumours, tumours visible on bronchoscopy requiring sleeve resection, hilar lymphadenopathy, N2 disease, history of neoadjuvant chemotherapy or radiation, previous thoracic surgery or pleurodesis. A retrospective study of 410 patients (143 women, mean age 61.5 ± 13.1 years (84–15) treated by VATS lobectomy between 1996 and 2011 was performed at our institution. VATS lobectomy was performed for lung cancer (n = 364, 88.9%), pulmonary metastasis (n = 25, 5.8%) and non-neoplastic diseases (n = 21, 5.1%). In lung cancer, a systematic radical lymph node dissection was performed. There was no intraoperative death. The conversion rate was 6.1% (n = 25): bleeding (n = 4), extended pleural adhesion (n = 6, 1.4%), technical difficulty (n = 6, 1.4%), tumour extension to the fissure or mediastinum or adenopathy (n = 7, 1.7%) and intolerance to one-lung ventilation (n = 2, 0.4%). The postoperative mortality rate was 1.2% (n = 5). Major complications occurred in 21 patients (5.1%). The mean number of mediastinal nodes removed was 14.6 (5–44) and 42 patients (10.2%) presented N2 disease at the definitive staging. The mean operating time was 152 (85–315) min. The mean drainage duration was 3.2 days (1–15). Mean postoperative length of hospital stay before return at home was 6.8 days (3–75) and 5.5 days in patients without major complications. There was no port site recurrence. Kaplan–Meier 3-year survival rates were 76.5% for Stage I and 87.3% for Stage IA, 58% for Stage II and 61% for Stage III. VATS lobectomy is an acceptable alternative and seems equivalent to open lobectomy in terms of complications and oncological value. Our experience prompts us to consider VATS lobectomy for early stage NSCLC as the first surgical approach in view of the improvement in outcome, provided that the procedure is performed by a surgeon with adequate experience with this approach.Keywords
This publication has 23 references indexed in Scilit:
- Video-assisted thoracoscopic surgery (VATS) lobectomy: Catastrophic intraoperative complicationsThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Long-term Survival After Videothoracoscopic Lobectomy for Stage I Lung CancerChest, 2004
- Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobeThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Thoracoscopic lobectomy: a safe and effective strategy for patients with stage i lung cancerThe Annals of Thoracic Surgery, 2002
- A prospective trial of systematic nodal dissection for lung cancer by video-assisted thoracic surgery: can it be perfect?The Annals of Thoracic Surgery, 2002
- Video‐assisted Thoracoscopic Lobectomy Achieves a Satisfactory Long‐term Prognosis in Patients with Clinical Stage IA Lung CancerWorld Journal of Surgery, 2000
- Is complete systematic nodal dissection by thoracoscopic surgery possible? A prospective trial of video-assisted lobectomy for cancer of the right lungThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Thirty-day operative mortality for thoracotomy in lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Thoracoscopic major lung resection--indications, technique, and early results: experience from two centers in Asia.1997
- Prospective Assessment of 30-Day Operative Morbidity for Surgical Resections in Lung CancerChest, 1994